MTIF3 (mitochondrial translational initiation factor 3) is a critical regulator of mitochondrial protein synthesis that functions by binding to the 28S ribosomal subunit and facilitating the initiation of translation on leaderless mitochondrial mRNAs 1. Unlike bacterial systems, MTIF3 displays selective activity—it is essential for translation of polycistronic transcripts like ATP8/ATP6 but not required for leaderless mRNA translation in vitro, demonstrating an important evolutionary divergence in mitochondrial translation 1. MTIF3 is indispensable for coordinated assembly of oxidative phosphorylation (OXPHOS) complexes; heart- and skeletal muscle-specific MTIF3 loss causes cardiomyopathy and uncoordinated mitochondrial protein synthesis despite increased translation rates 2. Functionally, MTIF3 maintains mitochondrial respiration and fatty acid oxidation in adipocytes; genetic variation at rs67785913 affecting MTIF3 expression is causally associated with obesity through impaired mitochondrial function and OXPHOS assembly 3. Beyond metabolic tissues, MTIF3 dysfunction contributes to pathological conditions: it is downregulated in childhood allergic asthma with negative correlation to B cell populations 4, serves as a diagnostic biomarker in heart failure where overexpression reduces cardiomyocyte proliferation 5, and is implicated in sepsis pathogenesis through multi-omics associations 6. Additionally, MTIF3 expression modulates mitochondrial complex I levels and reverse electron transport-mediated ROS production in chondrocyte degeneration 7.